Gene · 7175
Papers1,702
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,702
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Spectrum of Spitz Melanocytic Lesions: From Morphologic Diagnosis to Molecular Classification. | Front Oncol | 2022 | 35747831 | PubTator, text mining | PubMed |
| Antibiotic-Induced Treatments Reveal Stress-Responsive Gene Expression in the Endangered Lichen Lobaria pulmonaria | J Fungi (Basel) | 2022 | 35736108 | PubTator, text mining | PubMed |
| Nuclear pore complex acetylation regulates mRNA export and cell cycle commitment in budding yeast. | EMBO J | 2022 | 35735140 | PubTator, text mining | PubMed |
| Transcription of the Envelope Protein by 1-L Protein-RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis. | Curr Issues Mol Biol | 2022 | 35723340 | PubTator, text mining | PubMed |
| NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification. | Am J Surg Pathol | 2022 | 35713627 | PubTator, text mining | PubMed |
| Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins. | PLoS One | 2022 | 35704642 | PubTator, text mining | PubMed |
| Expression of Concern: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma. | Biosci Rep | 2022 | 35699969 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| How RNases Shape Mitochondrial Transcriptomes. | Int J Mol Sci | 2022 | 35682820 | PubTator, text mining | PubMed |
| The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma. | Transl Oncol | 2022 | 35660848 | PubTator, text mining | PubMed |
| Integrated proteogenomic characterization of urothelial carcinoma of the bladder. | J Hematol Oncol | 2022 | 35659036 | PubTator, text mining | PubMed |
| Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus. | Viruses | 2022 | 35632621 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveals diverse stimuli activate distinct signaling pathways during neutrophil activation. | Cell Tissue Res | 2022 | 35622142 | PubTator, text mining | PubMed |
| Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence. | Cancer Med | 2022 | 35616090 | PubTator, text mining | PubMed |
| ZC3HC1 is a structural element of the nuclear basket effecting interlinkage of TPR polypeptides. | Mol Biol Cell | 2022 | 35609216 | PubTator, text mining | PubMed |
| Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy. | Blood Adv | 2022 | 35605246 | PubTator, text mining | PubMed |
| Spelling out the roles of individual nucleoporins in nuclear export of mRNA. | Nucleus | 2022 | 35593254 | PubTator, text mining | PubMed |
| Evaluation of cfDNA as an early detection assay for dense tissue breast cancer. | Sci Rep | 2022 | 35589867 | PubTator, text mining | PubMed |
| Multifaceted regulation and functions of 53BP1 in NHEJ‑mediated DSB repair (Review). | Int J Mol Med | 2022 | 35583003 | PubTator, text mining | PubMed |
| Identifying common transcriptome signatures of cancer by interpreting deep learning models. | Genome Biol | 2022 | 35581644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7175/papers?page=19